oncotarget（Oncotarget The Future of Cancer Research）

Oncotarget: The Future of Cancer Research

Introduction

Cancer is one of the deadliest diseases in the world, causing millions of deaths every year. While significant progress has been made in cancer research, there is still much that we don't know about this complex disease. Fortunately, Oncotarget is helping to fill some of these gaps by providing a platform for researchers to share their findings and collaborate on new discoveries. In this article, we'll explore the key features of Oncotarget and why it is such an important resource for cancer researchers.

The Key Features of Oncotarget

Oncotarget is a peer-reviewed, multidisciplinary journal that publishes research papers in all areas of oncology. The journal was founded in 2010 by Mikhail Blagosklonny and Andrei V. Gudkov, both of whom are professors at the Roswell Park Cancer Institute in Buffalo, New York. Since its inception, Oncotarget has become one of the most important journals in the field of cancer research, with an impact factor of 5.168 in 2020. One of the key features of Oncotarget is its rapid publication process. The journal uses an online manuscript submission system, which allows researchers to submit their papers quickly and easily. Once a paper is submitted, it is reviewed by two or more experts in the field, who provide feedback on the paper's strengths and weaknesses. If the paper is accepted, it is published online within a few weeks, allowing researchers to share their findings with the scientific community in a timely manner. Another important feature of Oncotarget is its interdisciplinary approach to cancer research. The journal welcomes papers from all areas of oncology, including basic and translational research, clinical trials, and population-based studies. This interdisciplinary approach allows researchers to share their findings across disciplines, which can lead to new insights and discoveries.

The Future of Oncotarget

Oncotarget has already made a significant impact on cancer research, but the journal's founders have even bigger ambitions for the future. In addition to publishing papers, Oncotarget is also working to create a community of researchers who can collaborate on new projects and share resources. The journal hosts an annual conference, which brings together researchers from all over the world to discuss the latest developments in cancer research. One of the most exciting developments in Oncotarget's future is the journal's expansion into new areas of research. The journal recently announced that it would be expanding its scope to include papers on aging and aging-related diseases, such as Alzheimer's disease and Parkinson's disease. This expansion will allow researchers to explore the connections between cancer and other diseases, which could lead to new treatments and cures.

Conclusion

In conclusion, Oncotarget is an essential resource for cancer researchers, providing a platform for rapid publication and interdisciplinary collaboration. The journal's founders have ambitious plans for the future, including expanding into new areas of research and creating a global community of researchers. With its commitment to excellence and innovation, Oncotarget is helping to lead the way in the fight against cancer.